News
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
6d
Zacks.com on MSNCVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.
Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...
The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...
The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...
Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...
Bob Myers said what everyone's been thinking about Stephen A. Smith over the last few weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results